A Phase II Trial of LY317615 in Patients With Recurrent High-Grade Gliomas
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Enzastaurin (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 05 Nov 2005 New trial record.